NCR3LG1 Gene

HGNC Family Immunoglobulin superfamily domain containing, Endogenous ligands
Name natural killer cell cytotoxicity receptor 3 ligand 1
Description B7H6 belongs to the B7 family (see MIM 605402) and is selectively expressed on tumor cells. Interaction of B7H6 with NKp30 (NCR3; MIM 611550) results in natural killer (NK) cell activation and cytotoxicity (Brandt et al., 2009 [PubMed 19528259]).[supplied by OMIM, Jan 2011]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNCR3LG1, also known as B7‐H6, is a member of the B7 family that is uniquely expressed on stressed and transformed cells, where it serves as a ligand for the activating receptor NKp30 on natural killer (NK) cells. Engagement of B7‐H6 with NKp30 triggers NK cell cytotoxicity and cytokine secretion, thereby promoting tumor cell recognition and elimination. This direct interaction has been substantiated at both functional and structural levels, emphasizing its role as an “induced self” signal in innate immune surveillance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its role in triggering NK cell activation, tumor‐derived B7‐H6 can be released into the microenvironment by proteolytic shedding, a mechanism that contributes to immune escape. Soluble forms of B7‐H6, generated through the action of metalloproteases, have been shown to attenuate NK cell responsiveness and modulate other immune cell subsets such as group 2 innate lymphoid cells (ILC2s), thereby facilitating tumor immune evasion. The dysregulated release of B7‐H6 has also been observed in hematological malignancies and even in non‐malignant contexts such as liver failure associated with hepatitis B, illustrating its versatile role in modulating immune responses."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nB7‐H6 expression is not exclusively restricted to tumor cells; in fact, its up‐regulation can also be induced in nontransformed cells such as proinflammatory monocytes and neutrophils upon stimulation with toll‐like receptor ligands and cytokines. This inducible expression under inflammatory conditions, as demonstrated in sepsis, suggests that B7‐H6 may also participate in the regulation of immune responses beyond tumor surveillance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its immunomodulatory functions, B7‐H6 has been implicated in tumor cell–intrinsic processes that influence cancer progression. In several cancer types—including ovarian, glioma, esophageal squamous cell, cervical, medulloblastoma, and melanoma—B7‐H6 expression often correlates with enhanced proliferation, migration, invasion, and even stem‐like features, which in many instances are associated with poor clinical outcomes. Evidence from these studies also points to its dual role: while in some tumors elevated B7‐H6 levels are linked to aggressive behavior and worse prognosis, in others (such as hepatocellular carcinoma) its presence may indicate a more favorable response. This dichotomy underscores the complexity of B7‐H6’s involvement in tumor biology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "21"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe emerging understanding of B7‐H6’s molecular function has further stimulated the development of novel therapeutic approaches. Preclinical studies in nonhuman primate models have confirmed that NK cell recognition via NKp30 is conserved across species, strengthening the rationale for targeting the B7‐H6/NKp30 axis in cancer. Moreover, innovative strategies—such as the engineering of fusion proteins and the design of immunostimulatory peptides that mimic B7‐H6’s binding interface—have shown promise in enhancing NK cell–mediated anti‐tumor responses, thereby offering new avenues for immunotherapy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn summary, the multifaceted roles of NCR3LG1/B7‐H6—as both an activator of NK cell cytotoxicity and a modulator of tumor and inflammatory cell behavior—underscore its significance in tumor immunosurveillance, immune evasion, and cancer progression. Its variable expression and the context‐dependent outcomes associated with its engagement mark B7‐H6 as a valuable biomarker and a potential therapeutic target across a broad spectrum of malignancies, warranting further investigation into its precise regulatory mechanisms and clinical applications."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_f", "ref": "10"}, {"type": "fg_f", "ref": "24"}, {"type": "fg_f", "ref": "3"}, {"type": "fg_f", "ref": "22"}, {"type": "fg_f", "ref": "25"}, {"type": "fg_f", "ref": "4"}, {"type": "fg_f", "ref": "11"}, {"type": "fg_f", "ref": "6"}, {"type": "fg_f", "ref": "23"}, {"type": "fg_f", "ref": "12"}, {"type": "fg_f", "ref": "8"}, {"type": "fg_fs", "start_ref": "13", "end_ref": "21"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Cameron S Brandt, Myriam Baratin, Eugene C Yi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20090681"}], "href": "https://doi.org/10.1084/jem.20090681"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19528259"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19528259"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yili Li, Qian Wang, Roy A Mariuzza "}, {"type": "b", "children": [{"type": "t", "text": "Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20102548"}], "href": "https://doi.org/10.1084/jem.20102548"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21422170"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21422170"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Eva Schlecker, Nathalie Fiegler, Annette Arnold, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-13-3017"}], "href": "https://doi.org/10.1158/0008-5472.CAN-13-3017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24780758"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24780758"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Michaela Semeraro, Sylvie Rusakiewicz, Véronique Minard-Colin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Transl Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scitranslmed.aaa2327"}], "href": "https://doi.org/10.1126/scitranslmed.aaa2327"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25877893"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25877893"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yong Zou, Junjie Bao, Xingfei Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0134568"}], "href": "https://doi.org/10.1371/journal.pone.0134568"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26241657"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26241657"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Guoshuai Cao, Jian Wang, Xiaodong Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.674010"}], "href": "https://doi.org/10.1074/jbc.M115.674010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26472927"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26472927"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Maryam Salimi, Luzheng Xue, Helen Jolin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1501102"}], "href": "https://doi.org/10.4049/jimmunol.1501102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26582946"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26582946"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Sara Trabanelli, Mathieu F Chevalier, Amaia Martinez-Usatorre, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-017-00678-2"}], "href": "https://doi.org/10.1038/s41467-017-00678-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28928446"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28928446"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Jorge Gutierrez-Franco, Rodolfo Hernandez-Gutierrez, Miriam Ruth Bueno-Topete, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of B7H6, an endogenous ligand for the NK cell activating receptor NKp30, reveals the identity of two different soluble isoforms during normal human pregnancy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunobiology (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.imbio.2017.10.012"}], "href": "https://doi.org/10.1016/j.imbio.2017.10.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29055565"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29055565"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jessica Matta, Myriam Baratin, Laurent Chiche, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2013-01-481705"}], "href": "https://doi.org/10.1182/blood-2013-01-481705"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23687088"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23687088"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yi Zhou, Yun Xu, Lujun Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "B7-H6 expression correlates with cancer progression and patient's survival in human ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26464699"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26464699"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Tianwei Jiang, Wei Wu, Huasheng Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of B7-H6 in human glioma tissues promotes tumor progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.16391"}], "href": "https://doi.org/10.18632/oncotarget.16391"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28415577"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28415577"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Fengyuan Che, Xiaoli Xie, Long Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Immunopharmacol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.intimp.2018.03.020"}], "href": "https://doi.org/10.1016/j.intimp.2018.03.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29679856"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29679856"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Huan Zhou, Jun Dong, Liyi Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The prognostic value of B7-H6 in esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-019-54731-9"}], "href": "https://doi.org/10.1038/s41598-019-54731-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31792298"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31792298"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Gloria Yareli Gutierrez-Silerio, Ramon Antonio Franco-Topete, Jesse Haramati, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Positive staining of the immunoligand B7-H6 in abnormal/transformed keratinocytes consistently accompanies the progression of cervical cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Immunol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12865-020-0341-9"}], "href": "https://doi.org/10.1186/s12865-020-0341-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32138659"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32138659"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Hanqing Chen, Yundi Guo, Jing Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Preferential Expression of B7-H6 in Glioma Stem-Like Cells Enhances Tumor Cell Proliferation via the c-Myc/RNMT Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2020/2328675"}], "href": "https://doi.org/10.1155/2020/2328675"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32322592"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32322592"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Hao Qiu, Shangshang Gao, Ziling Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dual role of B7-H6 as a novel prognostic marker in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "APMIS (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/apm.13099"}], "href": "https://doi.org/10.1111/apm.13099"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33220098"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33220098"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Boutheina Cherif, Hana Triki, Slim Charfi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immune checkpoint molecules B7-H6 and PD-L1 co-pattern the tumor inflammatory microenvironment in human breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-021-87216-9"}], "href": "https://doi.org/10.1038/s41598-021-87216-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33824367"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33824367"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Xuejing Liu, Ruimeng Guo, Yanying Xu "}, {"type": "b", "children": [{"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "B7-H6"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " as a Diagnostic Biomarker for Cervical Squamous Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genet Test Mol Biomarkers (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/gtmb.2020.0313"}], "href": "https://doi.org/10.1089/gtmb.2020.0313"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34280008"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34280008"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Jianing Fan, Yangyang Wang, Xiao Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "B7-H6 enhances F-actin rearrangement by targeting c-MYC activation to promote medulloblastoma migration and invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-023-01947-5"}], "href": "https://doi.org/10.1007/s12032-023-01947-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36692844"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36692844"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Alaleh Mohammadi, Souzan Najafi, Mohammad Amini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "B7H6 silencing increases chemosensitivity to dacarbazine and suppresses cell survival and migration in cutaneous melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Melanoma Res (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/CMR.0000000000000890"}], "href": "https://doi.org/10.1097/CMR.0000000000000890"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37053079"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37053079"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "T Müller, L Schlahsa, H J Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Allogeneic and xenogeneic anti-tumor effect of callithrix jacchus natural killer cells is dependent on NKp30 and B7-H6 interaction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Regul Homeost Agents (2014)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25001651"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25001651"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Mariana Phillips, Francesca Romeo, Constantine Bitsaktsis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "B7H6-derived peptides trigger TNF-α-dependent immunostimulatory activity of lymphocytic NK92-MI cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biopolymers (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/bip.22879"}], "href": "https://doi.org/10.1002/bip.22879"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27216712"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27216712"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xiao-Juan Chen, Jin Shen, Guang-Bo Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "B7-H6 protein expression has no prognostic significance in human gastric carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Oncol Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12253-013-9686-1"}], "href": "https://doi.org/10.1007/s12253-013-9686-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24242703"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24242703"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Xiuqin Zhang, Guangbo Zhang, Yan Qin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "B7-H6 expression in non-small cell lung cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2014)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25400778"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25400778"}]}]}]}
Synonyms B7H6, B7-H6, DKFZP686O24166
Proteins NR3L1_HUMAN
NCBI Gene ID 374383
API
Download Associations
Predicted Functions View NCR3LG1's ARCHS4 Predicted Functions.
Co-expressed Genes View NCR3LG1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View NCR3LG1's ARCHS4 Predicted Functions.

Functional Associations

NCR3LG1 has 4,111 functional associations with biological entities spanning 8 categories (molecular profile, functional term, phrase or reference, disease, phenotype or trait, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 70 datasets.

Click the + buttons to view associations for NCR3LG1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of NCR3LG1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of NCR3LG1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of NCR3LG1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with NCR3LG1 protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with NCR3LG1 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of NCR3LG1 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of NCR3LG1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of NCR3LG1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of NCR3LG1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing NCR3LG1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with NCR3LG1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with NCR3LG1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by NCR3LG1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with NCR3LG1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with NCR3LG1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with NCR3LG1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with NCR3LG1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at NCR3LG1 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of NCR3LG1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of NCR3LG1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with NCR3LG1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of NCR3LG1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of NCR3LG1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of NCR3LG1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of NCR3LG1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GlyGen Glycosylated Proteins ligands (chemical) binding NCR3LG1 protein from the GlyGen Glycosylated Proteins dataset.
GO Biological Process Annotations 2025 biological processes involving NCR3LG1 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing NCR3LG1 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by NCR3LG1 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by NCR3LG1 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of NCR3LG1 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of NCR3LG1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of NCR3LG1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of NCR3LG1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of NCR3LG1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with NCR3LG1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with NCR3LG1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with NCR3LG1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of NCR3LG1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of NCR3LG1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of NCR3LG1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of NCR3LG1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for NCR3LG1 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of NCR3LG1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of NCR3LG1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of NCR3LG1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of NCR3LG1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with NCR3LG1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of NCR3LG1 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for NCR3LG1 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of NCR3LG1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving NCR3LG1 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving NCR3LG1 protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2024 pathways involving NCR3LG1 protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of NCR3LG1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of NCR3LG1 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of NCR3LG1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at NCR3LG1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of NCR3LG1 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of NCR3LG1 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of NCR3LG1 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with NCR3LG1 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of NCR3LG1 gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of NCR3LG1 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of NCR3LG1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of NCR3LG1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of NCR3LG1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of NCR3LG1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with NCR3LG1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving NCR3LG1 protein from the WikiPathways Pathways 2024 dataset.